[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Page 6557]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02406]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
the Ministerio de Salud de la Rep[uacute]blica de Panam[aacute] (MINSA)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $10,000,000 for Year 1 of funding to the 
Ministerio de Salud de la Rep[uacute]blica de Panam[aacute] 
{MINSA{time} . The award will contribute to the achievement of 95-95-95 
targets (95% of HIV-positive individuals knowing their status, 95% of 
those receiving ART [Antiretroviral therapy], and 95% of those 
achieving viral suppression) in Panama by introducing or scaling up 
high-impact HIV prevention, testing, linkage, and treatment models 
across the continuum of care and strengthening HIV laboratory and 
information systems. Funding amounts for years 2-5 will be set at 
continuation.

DATES: The period for this award will be September 30, 2022 through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Lily de Leon, Center for Global 
Health, Centers for Disease Control and Prevention, 18 Avenida 11-37, 
Zona 15, VHIII, Telephone: 800-232-6348, Email: <a href="/cdn-cgi/l/email-protection#dbb2a1b4eb9bb8bfb8f5bcb4ad"><span class="__cf_email__" data-cfemail="3950435609795a5d5a175e564f">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The single-source award will include key HIV 
prevention and diagnosis activities: Index testing, differentiated 
service modalities at key population testing facilities, self-testing, 
Pre-Exposure Prophylaxis (PreP), rapid recency testing and response to 
clusters of recent transmission, and linkage to treatment for newly 
diagnosed individuals in Panama. Additionally, key HIV treatment 
activities will include linkage to care registries, early treatment 
initiation, differentiated service delivery models, opportunistic 
infection diagnosis and treatment, lost-to follow-up reengagement, 
quality assurance in Viral Load (VL) networks, and drug resistance 
monitoring.
    MINSA is in a unique position to conduct this work, as it is the 
sole organization authorized to oversee the regions and medical 
sanitary areas covered by health institutions deemed to be scattered 
and decentralized in Panama. Since its creation in 1969, MINSA has 
served to streamline programs within these areas by setting up 
satellite systems in which higher ranking institutions are responsible 
for coordinating collaboration between medical-sanitary area officials, 
urban doctors, and the general hospital staff of these complex 
institutions.

Summary of the Award

    Recipient: Ministerio de Salud de la Rep[uacute]blica de 
Panam[aacute] (MINSA).
    Purpose of the Award: The purpose of this award is to contribute to 
the achievement of 95-95-95 targets in Panama by introducing or scaling 
up high-impact HIV prevention, testing, linkage, and treatment models 
across the continuum of care and strengthening HIV laboratory and 
information systems.
    Amount of Award: The approximate year 1 funding amount will be 
$10,000,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the 
availability of funds. Fund amounts for years 2-5 will be set at 
continuation.
    Authority: This program is authorized under Public Law 108-25 (the 
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act 
of 2003).
    Period of Performance: September 30, 2022 through September 29, 
2027.

    Dated: February 1, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-02406 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>